Nathan Fowler

Associate Professor

  • 3994 Citations
  • 28 h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Nathan Fowler is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

Follicular Lymphoma
Disease-Free Survival
Therapeutics
Biopsy
Radiotherapy
7 Citations (Scopus)

AUGMENT: A Phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

Leonard, J. P., Trneny, M., Izutsu, K., Fowler, N., Hong, X., Zhu, J., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G. S., Pinto, A., Re, F., Fogliatto, L. M., Scheinberg, P., Flinn, I. W., Moreira, C., Cabeçadas, J., Liu, D., Kalambakas, S., Fustier, P. & 2 others, Wu, C. & Gribben, J. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1188-1199 12 p.

Research output: Contribution to journalArticle

Open Access
Lymphoma
Placebos
Neutropenia
Disease-Free Survival
Rituximab

Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes

Andraos, T. Y., Ayoub, Z., Nastoupil, L., Pinnix, C. C., Milgrom, S. A., Gunther, J., Ng, S. P., Fowler, N., Neelapu, S. S., Samaniego, F. & Dabaja, B. S., Jun 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 6, p. 381-389 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Radiotherapy
Disease-Free Survival
Survival
Drug Therapy
Open Access
B-Cell Lymphoma
Names
Lymphoma
Neck
Radiotherapy

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma

Pinnix, C. C., Milgrom, S. A., Cheah, C. Y., Gunther, J., Ludmir, E. B., Wogan, C. F., Nastoupil, L., Neelapu, S. S., Westin, J. R., Lee, H. J., Iyer, S. P., Steiner, R. E., Fayad, L. E., Fowler, N., Wang, L., Samaniego, F., Rodriguez, M. A., Rich, A. E., Medeiros, L. J. & Dabaja, B. S., Jan 1 2019, In : Blood Advances. 3, 9, p. 1356-1367 12 p.

Research output: Contribution to journalArticle

Open Access
Hodgkin Disease
Radiotherapy
Disease-Free Survival
Survival Rate
Therapeutics